Ibex LimitedNASDAQ: IBEX

IBEX Reports Record Quarterly Revenue and EPS, Raises Fiscal Year Guidance

· Issued by Ibex Limited via GlobeNewswire
  • Record second quarter Revenue, Adjusted EBITDA, EPS, and Adjusted EPS

  • Revenue grew 17% versus prior year quarter, fourth consecutive quarter of double-digit growth

  • EPS grew 45% year-over-year to $0.83 and adjusted EPS grew 46% to $0.87

  • Raises Fiscal Year Revenue and Adjusted EBITDA Guidance

WASHINGTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its second fiscal quarter ended December 31, 2025.

Three Months Ended December 31,

Six Months Ended December 31,

($ millions, except per share amounts)

2025

2024

Change

2025

2024

Change

Revenue

$

164.2

$

140.7

16.7

%

$

315.4

$

270.4

16.6

%

Net income

$

12.2

$

9.3

31.8

%

$

24.3

$

16.8

44.4

%

Net income margin

7.4

%

6.6

%

80

bps

7.7

%

6.2

%

150

bps

Adjusted net income (1)

$

12.8

$

9.6

33.0

%

$

25.9

$

18.6

39.0

%

Adjusted net income margin (1)

7.8

%

6.8

%

100

bps

8.2

%

6.9

%

130

bps

Adjusted EBITDA (1)

$

20.7

$

16.5

25.2

%

$

40.2

$

32.1

25.0

%

Adjusted EBITDA margin (1)

12.6

%

11.8

%

80

bps

12.7

%

11.9

%

80

bps

Earnings per share – diluted (2)

$

0.83

$

0.57

44.9

%

$

1.65

$

1.00

65.7

%

Adjusted earnings per share – diluted (1,2)

$

0.87

$

0.59

46.3

%

$

1.77

$

1.11

59.6

%

(1) See accompanying Exhibits for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure.

(2) The current period percentages are calculated based on exact amounts, and therefore may not recalculate exactly using rounded numbers as presented.


“Ibex continued to carry forward the momentum built over the past two years, and delivered an outstanding second quarter with revenue growth of 17% to a record $164.2 million and adjusted EPS growth of 46%,” said Bob Dechant, ibex CEO. “This terrific performance is a direct result of exceptional operational delivery for our blue chip clients, enabling us to win significant market share from our competitors. In addition, our new logo engine delivered strong results.”

“We continue to advance our leadership position in deploying AI solutions for our clients both internally within our operations as well as deployment of AI Agents to interact with our clients’ customers. All this is enabling us to extend our separation from the traditional BPO pack.”

Second Quarter Financial Performance
Revenue

  • Revenue of $164.2 million, an increase of 16.7% from $140.7 million in the prior year quarter, was driven by growth in our top three verticals: HealthTech (+35.1%), Travel, Transportation and Logistics (+20.2%), and Retail & E-commerce (+17.2%), along with continued growth in the digital acquisition business.

Net Income and Earnings Per Share

  • Net income increased to $12.2 million compared to $9.3 million in the prior year quarter. Net income was favorably impacted by revenue growth in our higher margin offshore regions and lower selling, general, and administrative expenses as a percentage of revenue.

  • Net income margin increased to 7.4% compared to 6.6% in the prior year quarter.

  • Diluted earnings per share increased to $0.83 compared to $0.57 in the prior year quarter, primarily due to higher net income and lower diluted shares outstanding as a result of our share repurchase activities during fiscal 2025.

  • Non-GAAP adjusted net income increased to $12.8 million compared to $9.6 million in the prior year quarter (see Exhibit 1 for reconciliation).

  • Non-GAAP adjusted diluted earnings per share increased to $0.87 compared to $0.59 in the prior year quarter (see Exhibit 1 for reconciliation).

Non-GAAP adjusted EBITDA

  • Adjusted EBITDA increased to $20.7 million compared to $16.5 million in the prior year quarter (see Exhibit 2 for reconciliation).

  • Adjusted EBITDA margin increased to 12.6% compared to 11.8% in the prior year quarter (see Exhibit 2 for reconciliation).

Cash Flow and Balance Sheet

  • Capital expenditures were $11.7 million compared to $4.3 million in the prior year quarter. The planned increase in capital expenditures during this quarter was driven by capacity expansion to meet strong demand in our highest margin regions.

  • Cash flow from operating activities was a second quarter record of $6.6 million compared to $1.1 million in the prior year quarter, which was primarily driven by an increase in our revenues resulting in increased profitability, as well as a lower use of working capital.

  • Free cash flow was $(5.1) million compared to $(3.2) million in the prior year quarter (see Exhibit 3 for reconciliation).

  • During the quarter, we repurchased 78,200 shares for $2.9 million.

  • Net cash was $14.0 million, an improvement of $0.3 million compared to net cash of $13.7 million as of June 30, 2025 (see Exhibit 4 for reconciliation).

Second Quarter Review and Fiscal 2026 Business Outlook
“In the second quarter we continued to build on the momentum we’ve generated over the past twelve months. Our strong quarterly revenue performance was again led by meaningful growth in our higher margin geographies, services, and vertical markets, particularly in HealthTech. This combination of drivers led to a record quarterly adjusted EBITDA of $20.7 million,” said Taylor Greenwald, CFO of ibex.

“As we look ahead to the second half of the fiscal year, our robust balance sheet is enabling us to make opportunistic investments to further extend our current AI leadership position. Additionally, with the clear returns we’ve already seen, we are proactively investing in increased sales resources as well as capacity in our top performing geographies, positioning us for further success in the years ahead. Considering our outperformance in fiscal 2026 thus far, we are confident in further raising our revenue and adjusted EBITDA guidance for the year.”

Fiscal Year 2026 Guidance

  • Revenue is expected to be in the range of $620 to $630 million, up from $605 to $620 million.

  • Adjusted EBITDA is expected to be in the range of $80 to $82 million, up from $78 to $81 million.

  • Capital expenditures are expected to be at the upper end of our previous range of $20 to $25 million.

Conference Call and Webcast Information

IBEX Limited will host a conference call and live webcast to discuss its second quarter of fiscal year 2026 financial results at 4:30 p.m. Eastern Time today, February 5, 2026. We will also post to this section of our website the earning slides, which will accompany our conference call and live webcast, and encourage you to review the information that we make available on our website.

Live and archived webcasts can be accessed at: https://investors.ibex.co/.

Financial Information
This announcement does not contain sufficient information to constitute an interim financial report as defined in Financial Accounting Standards ASC 270, “Interim Reporting.” The financial information in this press release has not been audited.

Non-GAAP Financial Measures
We present non-GAAP financial measures because we believe that they and other similar measures are widely used by certain investors, securities analysts and other interested parties as supplemental measures of performance and liquidity. We also use these measures internally to establish forecasts, budgets and operational goals to manage and monitor our business, as well as evaluate our underlying historical performance, as we believe that these non-GAAP financial measures provide a more helpful depiction of our performance of the business by encompassing only relevant and manageable events, enabling us to evaluate and plan more effectively for the future. The non-GAAP financial measures may not be comparable to other similarly titled measures of other companies, have limitations as analytical tools, and should not be considered in isolation or as a substitute for analysis of our operating results as reported in accordance with accounting principles generally accepted in the United States (“GAAP”). Non-GAAP financial measures and ratios are not measurements of our performance, financial condition or liquidity under GAAP and should not be considered as alternatives to operating profit or net income / (loss) or as alternatives to cash flow from operating, investing or financing activities for the period, or any other performance measures, derived in accordance with GAAP.

ibex is not providing a quantitative reconciliation of forward-looking non-GAAP adjusted EBITDA to the most directly comparable GAAP measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items without unreasonable effort. These items include, but are not limited to, non-recurring expenses, foreign currency gains and losses, and stock-based compensation expense. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period.

About ibex
ibex helps the world’s preeminent brands more effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and CX surveys and feedback analytics.

Forward Looking Statements
In addition to historical information, this press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” “forecast,” or the negative of these terms or other similar expressions. These statements include, but are not limited to, statements regarding our future financial and operating performance, including our outlook and guidance, and our strategies, priorities and business plans. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could impact our actual results include: our ability to attract new business and retain key clients; our profitability based on our utilization, pricing and managing costs; the potential for our clients or potential clients to consolidate; our clients deciding to enter into or further expand their insourcing activities and current trends toward outsourcing services may reverse; general economic uncertainty in global markets and unfavorable economic conditions, including inflation, rising interest rates, recession, foreign exchange fluctuations and supply-chain issues; our ability to manage our international operations, particularly in the Philippines, Jamaica, Pakistan and Nicaragua; natural events, health epidemics, global geopolitical conditions, including developing or ongoing conflicts, widespread civil unrest, terrorist attacks and other attacks of violence involving any of the countries in which we or our clients operate; our ability to anticipate, develop and implement information technology solutions that keep pace with evolving industry standards and changing client demands, including the effective adoption of Artificial Intelligence into our offerings; our ability to recruit, engage, motivate, manage and retain our global workforce; our ability to comply with applicable laws and regulations, including those regarding privacy, data protection and information security, employment and anti-corruption; the effect of cyberattacks or cybersecurity vulnerabilities on our information technology systems; the impact of tax matters, including new legislation and actions by taxing authorities; and other factors discussed in the “Risk Factors” described in our periodic reports filed with the U.S. Securities and Exchange Commission (“SEC”), including our annual reports on Form 10-K, quarterly reports on Form 10-Q, and past filings on Form 20-F, and any other risk factors we include in subsequent filings with the SEC. Because of these uncertainties, you should not make any investment decisions based on our estimates and forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements for any reason after the date of this press release whether as a result of new information, future events or otherwise.

IR Contact: ir@ibex.co

Media Contact: Daniel Burris, VP, Marketing and Communication, ibex, daniel.burris@ibex.co

IBEX LIMITED AND SUBSIDIARIES
Consolidated Balance Sheets
(Unaudited)
(in thousands)

December 31,
2025

June 30,
2025

Assets

Current assets

Cash and cash equivalents

$

15,460

$

15,350

Accounts receivable, net

130,505

117,136

Prepaid expenses

9,171

9,443

Due from related parties

—

40

Tax advances and receivables

1,451

1,522

Other current assets

1,937

2,128

Total current assets

158,524

145,619

Non-current assets

Property and equipment, net

44,217

32,563

Operating lease assets

57,157

62,276

Goodwill

11,832

11,832

Deferred tax asset, net

8,595

7,163

Other non-current assets

15,472

13,762

Total non-current assets

137,273

127,596

Total assets

$

295,797

$

273,215

Liabilities and stockholders' equity

Current liabilities

Accounts payable and accrued liabilities

$

24,632

$

18,692

Accrued payroll and employee-related liabilities

37,355

38,588

Current deferred revenue

8,521

5,498

Current operating lease liabilities

14,411

14,332

Current debt

837

823

Due to related parties

—

22

Income taxes payable

749

1,986

Total current liabilities

86,505

79,941

Non-current liabilities

Non-current deferred revenue

1,472

1,130

Non-current operating lease liabilities

48,499

53,804

Long-term debt

594

796

Other non-current liabilities

4,212

3,235

Total non-current liabilities

54,777

58,965

Total liabilities

141,282

138,906

Stockholders' equity

Common Stock

2

1

Treasury stock

(108,893

)

(103,338

)

Additional paid-in capital

223,927

218,241

Accumulated other comprehensive loss

(10,521

)

(6,336

)

Retained earnings

50,000

25,741

Total stockholders' equity

154,515

134,309

Total liabilities and stockholders' equity

$

295,797

$

273,215

IBEX LIMITED AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income
(Unaudited)
(in thousands, except per share data)

Three Months Ended December 31,

Six Months Ended December 31,

2025

2024

2025

2024

Revenue

$

164,221

$

140,682

$

315,400

$

270,399

Cost of services (exclusive of depreciation and amortization presented separately below)

116,629

98,762

223,206

188,803

Selling, general and administrative

27,555

25,706

54,080

51,921

Depreciation and amortization

4,750

4,286

9,128

8,655

Total operating expenses

148,934

128,754

286,414

249,379

Income from operations

15,287

11,928

28,986

21,020

Interest income

59

311

89

894

Interest expense

(248

)

(620

)

(465

)

(782

)

Income before income taxes

15,098

11,619

28,610

21,132

Provision for income tax expense

(2,881

)

(2,351

)

(4,351

)

(4,333

)

Net income

$

12,217

$

9,268

$

24,259

$

16,799

Other comprehensive income

Foreign currency translation adjustments

$

(369

)

$

(911

)

$

(1,581

)

$

477

Unrealized (loss) / gain on cash flow hedging instruments, net of tax

(416

)

(193

)

(2,604

)

186

Total other comprehensive (loss) / income

(785

)

(1,104

)

(4,185

)

663

Total comprehensive income

$

11,432

$

8,164

$

20,074

$

17,462

Net income per share

Basic

$

0.91

$

0.61

$

1.81

$

1.05

Diluted

$

0.83

$

0.57

$

1.65

$

1.00

Weighted average common shares outstanding

Basic

13,469

15,126

13,414

16,007

Diluted

14,737

16,456

14,673

16,977

IBEX LIMITED AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Unaudited)
(in thousands)

Three Months Ended December 31,

Six Months Ended December 31,

2025

2024

2025

2024

CASH FLOWS FROM OPERATING ACTIVITIES

Net income

$

12,217

$

9,268

$

24,259

$

16,799

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

4,750

4,286

9,128

8,655

Noncash lease expense

3,488

3,083

6,925

6,409

Deferred income tax

(370

)

(637

)

(1,432

)

(767

)

Stock-based compensation expense

1,114

1,235

3,664

1,905

Allowance for expected credit losses

173

240

225

323

Change in assets and liabilities:

Increase in accounts receivable

(14,591

)

(14,856

)

(13,576

)

(22,505

)

Decrease / (increase) in prepaid expenses and other current assets

1,266

722

(2,206

)

(1,013

)

(Decrease) / increase in accounts payable and accrued liabilities

(546

)

(1,496

)

(857

)

3,078

Increase in deferred revenue

2,751

2,386

3,365

2,465

Decrease in operating lease liabilities

(3,608

)

(3,090

)

(7,181

)

(6,446

)

Net cash inflow from operating activities

6,644

1,141

22,314

8,903

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of property and equipment

(11,732

)

(4,319

)

(19,371

)

(7,949

)

Net cash outflow from investing activities

(11,732

)

(4,319

)

(19,371

)

(7,949

)

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from line of credit

11,000

9,100

11,000

9,160

Repayments of line of credit

(11,000

)

(1,600

)

(11,000

)

(1,660

)

Proceeds from the exercise of options

936

342

3,348

724

Taxes paid related to net share settlement of equity awards

(41

)

—

(41

)

—

Principal payments on finance leases

(257

)

(182

)

(549

)

(353

)

Purchase of treasury shares

(2,786

)

(46,562

)

(5,553

)

(51,369

)

Net cash outflow from financing activities

(2,148

)

(38,902

)

(2,795

)

(43,498

)

Effects of exchange rate difference on cash and cash equivalents

2

(19

)

(38

)

30

Net (decrease) / increase in cash and cash equivalents

(7,234

)

(42,099

)

110

(42,514

)

Cash and cash equivalents, beginning

22,694

62,305

15,350

62,720

Cash and cash equivalents, ending

$

15,460

$

20,206

$

15,460

$

20,206


IBEX LIMITED AND SUBSIDIARIES

Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures

EXHIBIT 1: Adjusted net income, adjusted net income margin, and adjusted earnings per share

We define adjusted net income as net income before the effect of the following items: severance costs, foreign currency gains and losses, and stock-based compensation expense, net of the tax impact of such adjustments. We define adjusted net income margin as adjusted net income divided by revenue. We define adjusted earnings per share as adjusted net income divided by weighted average diluted shares outstanding.

The following table provides a reconciliation of net income to adjusted net income, net income margin to adjusted net income margin, and diluted earnings per share to adjusted earnings per share for the periods presented:

Three Months Ended December 31,

Six Months Ended December 31,

($000s, except per share amounts)

2025

2024

2025

2024

Net income

$

12,217

$

9,268

$

24,259

$

16,799

Net income margin

7.4

%

6.6

%

7.7

%

6.2

%

Severance costs

—

—

159

—

Foreign currency (gain) / loss

(445

)

(912

)

(1,765

)

545

Stock-based compensation expense

1,114

1,235

3,664

1,905

Total adjustments

$

669

$

323

$

2,058

$

2,450

Tax impact of adjustments1

(95

)

24

(392

)

(602

)

Adjusted net income

$

12,791

$

9,615

$

25,925

$

18,647

Adjusted net income margin

7.8

%

6.8

%

8.2

%

6.9

%

Diluted earnings per share

$

0.83

$

0.57

$

1.65

$

1.00

Per share impact of adjustments to net income

0.04

0.02

0.12

0.11

Adjusted earnings per share

$

0.87

$

0.59

$

1.77

$

1.11

Weighted average diluted shares outstanding

14,737

16,456

14,673

16,977


________________________________
1The tax impact of each adjustment is calculated using the effective tax rate in the relevant jurisdictions.


EXHIBIT 2: EBITDA, adjusted EBITDA, and adjusted EBITDA margin

EBITDA is a non-GAAP profitability measure that represents net income before the effect of the following items: interest expense, income tax expense, and depreciation and amortization. Adjusted EBITDA is a non-GAAP profitability measure that represents EBITDA before the effect of the following items: severance costs, interest income, foreign currency gains and losses, and stock-based compensation expense. Adjusted EBITDA margin is a non-GAAP profitability measure that represents adjusted EBITDA divided by revenue.

The following table provides a reconciliation of net income to EBITDA and adjusted EBITDA and net income margin to adjusted EBITDA margin for the periods presented:

Three Months Ended December 31,

Six Months Ended December 31,

($000s)

2025

2024

2025

2024

Net income

$

12,217

$

9,268

$

24,259

$

16,799

Net income margin

7.4

%

6.6

%

7.7

%

6.2

%

Interest expense

248

620

465

782

Income tax expense

2,881

2,351

4,351

4,333

Depreciation and amortization

4,750

4,286

9,128

8,655

EBITDA

$

20,096

$

16,525

$

38,203

$

30,569

Severance costs

—

—

159

—

Interest income

(59

)

(311

)

(89

)

(894

)

Foreign currency (gain) / loss

(445

)

(912

)

(1,765

)

545

Stock-based compensation expense

1,114

1,235

3,664

1,905

Adjusted EBITDA

$

20,706

$

16,537

$

40,172

$

32,125

Adjusted EBITDA margin

12.6

%

11.8

%

12.7

%

11.9

%


EXHIBIT 3: Free cash flow

We define free cash flow as net cash provided by operating activities less capital expenditures.

Three Months Ended December 31,

Six Months Ended December 31,

($000s)

2025

2024

2025

2024

Net cash provided by operating activities

$

6,644

$

1,141

$

22,314

$

8,903

Less: capital expenditures

11,732

4,319

19,371

7,949

Free cash flow

$

(5,088

)

$

(3,178

)

$

2,943

$

954


EXHIBIT 4: Net cash

We define net cash as total cash and cash equivalents less debt.

December 31,

June 30,

($000s)

2025

2025

Cash and cash equivalents

$

15,460

$

15,350

Debt

Current

$

837

$

823

Non-current

594

796

Total debt

$

1,431

$

1,619

Net cash

$

14,029

$

13,731